MENU SEARCH
Tags: Drugs Controller General of India | DCGI | emergency use authorisation | EUA | Bharat Biotech | Covaxin

DCGI grants restricted EUA to Covaxin for 6-12 age group

DCGI grants restricted EUA to Covaxin for 6-12 age group

Tuesday, 26 April 2022

New Delhi: The Drugs Controller General of India (DCGI) on Tuesday approved the restricted emergency use authorisation (EUA) to Bharat Biotech's Covaxin for children between the age of 6-12 years, sources said.

The DGCI has asked vaccine manufacturer to submit safety data including the data on adverse event with due analysis every 15 days for the first two months and monthly thereafter upto 5 months, said the source familiar with the development.

This development comes after the Subject Expert Committee (SEC) discussed recommendations for the restricted emergency use of Covaxin in children aged between 2-12 years.

However, the SEC, after a meeting on Thursday, had recommended restricted emergency use of Biological E's Covid-19 vaccine, Corbevax, in children aged 5-12 years.
 

© 2024 IANS. All rights reserved.

Newsfront
The Drugs Controller General of India (DCGI) on Tuesday approved the restricted emergency use authorisation (EUA) to Bharat Biotech's Covaxin for children between the age of 6-12 years, sources said.
Drugs Controller General of India, DCGI, emergency use authorisation, EUA, Bharat Biotech, Covaxin, children, Covid, Corona vaccine, Covid 19
120
2022-45-26
Tuesday, 26 April 2022
Newsmax Media, Inc.
 
TOP

Newsmax and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax India are trademarks of Newsmax Media, Inc.

NEWSMAX.IN
Real News for Real People
© Newsmax Media, Inc.
All Rights Reserved